Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
9.28
+1.13 (13.88%)
Dec 3, 2024, 1:55 PM EST - Market open
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $1.28 billion as of December 3, 2024. Its market cap has decreased by -1.45% in one year.
Market Cap
1.28B
Enterprise Value
320.76M
1-Year Change
-1.45%
Ranking
Category
Stock Price
$9.28
Market Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has decreased from $1.53B to $1.28B, a decrease of -16.67%. That is a compound annual growth rate of -3.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2024 | 1.12B | -17.06% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | 3.41B | 147.35% |
| Dec 31, 2019 | 1.38B | -10.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Brookdale Senior Living | 1.13B |
| Aveanna Healthcare Holdings | 1.12B |
| ANI Pharmaceuticals | 1.12B |
| Gyre Therapeutics | 1.07B |
| The Pennant Group | 1.07B |
| Avadel Pharmaceuticals | 1.07B |
| 89bio | 1.06B |
| OPKO Health | 1.05B |